As the global economy mends, the 2021 growth of Mumps Vaccine will have significant change from previous year. According to our (Publisher) latest study, the global Mumps Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Mumps Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Mumps Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Mumps Vaccine market, reaching US$ million by the year 2028. As for the Europe Mumps Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Mumps Vaccine players cover MedImmune, Johnson & Johnson, Merck & Co., Inc., and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mumps Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Child
Adult
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacies
Retail Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
MedImmune
Johnson & Johnson
Merck & Co., Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec, Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax, Inc.
Novartis
Sinovac Biotech, Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mumps Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mumps Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mumps Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Mumps Vaccine Segment by Type
2.2.1 Child
2.2.2 Adult
2.3 Mumps Vaccine Sales by Type
2.3.1 Global Mumps Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Mumps Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mumps Vaccine Sale Price by Type (2017-2022)
2.4 Mumps Vaccine Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Retail Pharmacies
2.5 Mumps Vaccine Sales by Application
2.5.1 Global Mumps Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Mumps Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mumps Vaccine Sale Price by Application (2017-2022)
3 Global Mumps Vaccine by Company
3.1 Global Mumps Vaccine Breakdown Data by Company
3.1.1 Global Mumps Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Mumps Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Mumps Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Mumps Vaccine Revenue by Company (2020-2022)
3.2.2 Global Mumps Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Mumps Vaccine Sale Price by Company
3.4 Key Manufacturers Mumps Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mumps Vaccine Product Location Distribution
3.4.2 Players Mumps Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mumps Vaccine by Geographic Region
4.1 World Historic Mumps Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Mumps Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mumps Vaccine Annual Revenue by Geographic Region
4.2 World Historic Mumps Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Mumps Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mumps Vaccine Annual Revenue by Country/Region
4.3 Americas Mumps Vaccine Sales Growth
4.4 APAC Mumps Vaccine Sales Growth
4.5 Europe Mumps Vaccine Sales Growth
4.6 Middle East & Africa Mumps Vaccine Sales Growth
5 Americas
5.1 Americas Mumps Vaccine Sales by Country
5.1.1 Americas Mumps Vaccine Sales by Country (2017-2022)
5.1.2 Americas Mumps Vaccine Revenue by Country (2017-2022)
5.2 Americas Mumps Vaccine Sales by Type
5.3 Americas Mumps Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mumps Vaccine Sales by Region
6.1.1 APAC Mumps Vaccine Sales by Region (2017-2022)
6.1.2 APAC Mumps Vaccine Revenue by Region (2017-2022)
6.2 APAC Mumps Vaccine Sales by Type
6.3 APAC Mumps Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mumps Vaccine by Country
7.1.1 Europe Mumps Vaccine Sales by Country (2017-2022)
7.1.2 Europe Mumps Vaccine Revenue by Country (2017-2022)
7.2 Europe Mumps Vaccine Sales by Type
7.3 Europe Mumps Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mumps Vaccine by Country
8.1.1 Middle East & Africa Mumps Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mumps Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Mumps Vaccine Sales by Type
8.3 Middle East & Africa Mumps Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mumps Vaccine
10.3 Manufacturing Process Analysis of Mumps Vaccine
10.4 Industry Chain Structure of Mumps Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mumps Vaccine Distributors
11.3 Mumps Vaccine Customer
12 World Forecast Review for Mumps Vaccine by Geographic Region
12.1 Global Mumps Vaccine Market Size Forecast by Region
12.1.1 Global Mumps Vaccine Forecast by Region (2023-2028)
12.1.2 Global Mumps Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mumps Vaccine Forecast by Type
12.7 Global Mumps Vaccine Forecast by Application
13 Key Players Analysis
13.1 MedImmune
13.1.1 MedImmune Company Information
13.1.2 MedImmune Mumps Vaccine Product Offered
13.1.3 MedImmune Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MedImmune Main Business Overview
13.1.5 MedImmune Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Mumps Vaccine Product Offered
13.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck & Co., Inc.
13.3.1 Merck & Co., Inc. Company Information
13.3.2 Merck & Co., Inc. Mumps Vaccine Product Offered
13.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck & Co., Inc. Main Business Overview
13.3.5 Merck & Co., Inc. Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Mumps Vaccine Product Offered
13.4.3 Sanofi Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Mumps Vaccine Product Offered
13.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Bavarian Nordic
13.6.1 Bavarian Nordic Company Information
13.6.2 Bavarian Nordic Mumps Vaccine Product Offered
13.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bavarian Nordic Main Business Overview
13.6.5 Bavarian Nordic Latest Developments
13.7 Astellas Pharma India
13.7.1 Astellas Pharma India Company Information
13.7.2 Astellas Pharma India Mumps Vaccine Product Offered
13.7.3 Astellas Pharma India Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Astellas Pharma India Main Business Overview
13.7.5 Astellas Pharma India Latest Developments
13.8 CSL Limited
13.8.1 CSL Limited Company Information
13.8.2 CSL Limited Mumps Vaccine Product Offered
13.8.3 CSL Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CSL Limited Main Business Overview
13.8.5 CSL Limited Latest Developments
13.9 Emergent BioSolutions
13.9.1 Emergent BioSolutions Company Information
13.9.2 Emergent BioSolutions Mumps Vaccine Product Offered
13.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Emergent BioSolutions Main Business Overview
13.9.5 Emergent BioSolutions Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Mumps Vaccine Product Offered
13.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Panacea Biotec, Ltd.
13.11.1 Panacea Biotec, Ltd. Company Information
13.11.2 Panacea Biotec, Ltd. Mumps Vaccine Product Offered
13.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Panacea Biotec, Ltd. Main Business Overview
13.11.5 Panacea Biotec, Ltd. Latest Developments
13.12 Biological E Limited
13.12.1 Biological E Limited Company Information
13.12.2 Biological E Limited Mumps Vaccine Product Offered
13.12.3 Biological E Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biological E Limited Main Business Overview
13.12.5 Biological E Limited Latest Developments
13.13 Bharat Biotech Ltd.
13.13.1 Bharat Biotech Ltd. Company Information
13.13.2 Bharat Biotech Ltd. Mumps Vaccine Product Offered
13.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Bharat Biotech Ltd. Main Business Overview
13.13.5 Bharat Biotech Ltd. Latest Developments
13.14 Novavax, Inc.
13.14.1 Novavax, Inc. Company Information
13.14.2 Novavax, Inc. Mumps Vaccine Product Offered
13.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Novavax, Inc. Main Business Overview
13.14.5 Novavax, Inc. Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Mumps Vaccine Product Offered
13.15.3 Novartis Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Sinovac Biotech, Ltd.
13.16.1 Sinovac Biotech, Ltd. Company Information
13.16.2 Sinovac Biotech, Ltd. Mumps Vaccine Product Offered
13.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sinovac Biotech, Ltd. Main Business Overview
13.16.5 Sinovac Biotech, Ltd. Latest Developments
13.17 Incepta Vaccine Limited
13.17.1 Incepta Vaccine Limited Company Information
13.17.2 Incepta Vaccine Limited Mumps Vaccine Product Offered
13.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Incepta Vaccine Limited Main Business Overview
13.17.5 Incepta Vaccine Limited Latest Developments
13.18 Valneva SE
13.18.1 Valneva SE Company Information
13.18.2 Valneva SE Mumps Vaccine Product Offered
13.18.3 Valneva SE Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Valneva SE Main Business Overview
13.18.5 Valneva SE Latest Developments
13.19 VBI Vaccines
13.19.1 VBI Vaccines Company Information
13.19.2 VBI Vaccines Mumps Vaccine Product Offered
13.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 VBI Vaccines Main Business Overview
13.19.5 VBI Vaccines Latest Developments
13.20 PT Bio Farma
13.20.1 PT Bio Farma Company Information
13.20.2 PT Bio Farma Mumps Vaccine Product Offered
13.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 PT Bio Farma Main Business Overview
13.20.5 PT Bio Farma Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Mumps Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mumps Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Child
Table 4. Major Players of Adult
Table 5. Global Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Mumps Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Mumps Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Mumps Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Mumps Vaccine Revenue by Application (2017-2022)
Table 13. Global Mumps Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Mumps Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Mumps Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Mumps Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Mumps Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Mumps Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Mumps Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Mumps Vaccine Producing Area Distribution and Sales Area
Table 21. Players Mumps Vaccine Products Offered
Table 22. Mumps Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mumps Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Mumps Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Mumps Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Mumps Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Mumps Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Mumps Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Mumps Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Mumps Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Mumps Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Mumps Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Mumps Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Mumps Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Mumps Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Mumps Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Mumps Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Mumps Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Mumps Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Mumps Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Mumps Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Mumps Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Mumps Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Mumps Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Mumps Vaccine
Table 66. Key Market Challenges & Risks of Mumps Vaccine
Table 67. Key Industry Trends of Mumps Vaccine
Table 68. Mumps Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Mumps Vaccine Distributors List
Table 71. Mumps Vaccine Customer List
Table 72. Global Mumps Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Mumps Vaccine Sales Market Forecast by Region
Table 74. Global Mumps Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Mumps Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Mumps Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Mumps Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Mumps Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Mumps Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Mumps Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Mumps Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Mumps Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Mumps Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Mumps Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Mumps Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Mumps Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Mumps Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Mumps Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Mumps Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Mumps Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Mumps Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MedImmune Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MedImmune Mumps Vaccine Product Offered
Table 94. MedImmune Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. MedImmune Main Business
Table 96. MedImmune Latest Developments
Table 97. Johnson & Johnson Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Mumps Vaccine Product Offered
Table 99. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Merck & Co., Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co., Inc. Mumps Vaccine Product Offered
Table 104. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Merck & Co., Inc. Main Business
Table 106. Merck & Co., Inc. Latest Developments
Table 107. Sanofi Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi Mumps Vaccine Product Offered
Table 109. Sanofi Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Serum Institute of India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Serum Institute of India Mumps Vaccine Product Offered
Table 114. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serum Institute of India Main Business
Table 116. Serum Institute of India Latest Developments
Table 117. Bavarian Nordic Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Bavarian Nordic Mumps Vaccine Product Offered
Table 119. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bavarian Nordic Main Business
Table 121. Bavarian Nordic Latest Developments
Table 122. Astellas Pharma India Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Astellas Pharma India Mumps Vaccine Product Offered
Table 124. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Astellas Pharma India Main Business
Table 126. Astellas Pharma India Latest Developments
Table 127. CSL Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. CSL Limited Mumps Vaccine Product Offered
Table 129. CSL Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. CSL Limited Main Business
Table 131. CSL Limited Latest Developments
Table 132. Emergent BioSolutions Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Emergent BioSolutions Mumps Vaccine Product Offered
Table 134. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Emergent BioSolutions Main Business
Table 136. Emergent BioSolutions Latest Developments
Table 137. GlaxoSmithKline Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. GlaxoSmithKline Mumps Vaccine Product Offered
Table 139. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. GlaxoSmithKline Main Business
Table 141. GlaxoSmithKline Latest Developments
Table 142. Panacea Biotec, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Panacea Biotec, Ltd. Mumps Vaccine Product Offered
Table 144. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Panacea Biotec, Ltd. Main Business
Table 146. Panacea Biotec, Ltd. Latest Developments
Table 147. Biological E Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Biological E Limited Mumps Vaccine Product Offered
Table 149. Biological E Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Biological E Limited Main Business
Table 151. Biological E Limited Latest Developments
Table 152. Bharat Biotech Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Bharat Biotech Ltd. Mumps Vaccine Product Offered
Table 154. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Bharat Biotech Ltd. Main Business
Table 156. Bharat Biotech Ltd. Latest Developments
Table 157. Novavax, Inc. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Novavax, Inc. Mumps Vaccine Product Offered
Table 159. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Novavax, Inc. Main Business
Table 161. Novavax, Inc. Latest Developments
Table 162. Novartis Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Novartis Mumps Vaccine Product Offered
Table 164. Novartis Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Novartis Main Business
Table 166. Novartis Latest Developments
Table 167. Sinovac Biotech, Ltd. Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Sinovac Biotech, Ltd. Mumps Vaccine Product Offered
Table 169. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Sinovac Biotech, Ltd. Main Business
Table 171. Sinovac Biotech, Ltd. Latest Developments
Table 172. Incepta Vaccine Limited Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Incepta Vaccine Limited Mumps Vaccine Product Offered
Table 174. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Incepta Vaccine Limited Main Business
Table 176. Incepta Vaccine Limited Latest Developments
Table 177. Valneva SE Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. Valneva SE Mumps Vaccine Product Offered
Table 179. Valneva SE Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Valneva SE Main Business
Table 181. Valneva SE Latest Developments
Table 182. VBI Vaccines Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 183. VBI Vaccines Mumps Vaccine Product Offered
Table 184. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. VBI Vaccines Main Business
Table 186. VBI Vaccines Latest Developments
Table 187. PT Bio Farma Basic Information, Mumps Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 188. PT Bio Farma Mumps Vaccine Product Offered
Table 189. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. PT Bio Farma Main Business
Table 191. PT Bio Farma Latest Developments
List of Figures
Figure 1. Picture of Mumps Vaccine
Figure 2. Mumps Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mumps Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Mumps Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mumps Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Child
Figure 10. Product Picture of Adult
Figure 11. Global Mumps Vaccine Sales Market Share by Type in 2021
Figure 12. Global Mumps Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Mumps Vaccine Consumed in Hospitals Pharmacies
Figure 14. Global Mumps Vaccine Market: Hospitals Pharmacies (2017-2022) & (K Units)
Figure 15. Mumps Vaccine Consumed in Retail Pharmacies
Figure 16. Global Mumps Vaccine Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 17. Global Mumps Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Mumps Vaccine Revenue Market Share by Application in 2021
Figure 19. Mumps Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Mumps Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Mumps Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Mumps Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Mumps Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Mumps Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Mumps Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Mumps Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Mumps Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Mumps Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Mumps Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Mumps Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Mumps Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Mumps Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Mumps Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Mumps Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Mumps Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Mumps Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Mumps Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Mumps Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Mumps Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Mumps Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Mumps Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Mumps Vaccine
Figure 63. Industry Chain Structure of Mumps Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles